Related Experiment Video

Updated: Apr 21, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κB pathways

Shih-ming Tsao1, Te-chun Hsia, Mei-chin Yin

  • 1a Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung City, Taiwan and Institute of Microbiology and Immunology , Chung Shan Medical University , Taichung City , Taiwan.

Nutrition and Cancer
|October 31, 2014
PubMed

Insights

Protocatechuic acid (PCA) exhibits cytotoxic effects against nonsmall cell lung cancer (NSCLC) cells. PCA inhibits NSCLC proliferation by downregulating key signaling pathways and reducing pro-tumorigenic factors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Nonsmall cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide.
  • Identifying novel therapeutic agents with potent anticancer activity is crucial for improving patient outcomes.
  • Protocatechuic acid (PCA), a natural phenolic compound, has demonstrated various biological activities.

Purpose of the Study:

  • To investigate the cytotoxic effects of protocatechuic acid (PCA) on three human nonsmall cell lung cancer (NSCLC) cell lines.
  • To elucidate the underlying molecular mechanisms by which PCA exerts its anticancer effects.
  • To evaluate PCA's potential as a therapeutic agent against NSCLC.

Main Methods:

  • Treatment of A549, H3255, and Calu-6 NSCLC cell lines with varying concentrations of PCA (1–8 μM).
  • Assessment of cell viability, apoptosis-related protein expression (Bax, Bcl-2, cleaved caspase-3), mitochondrial membrane potential, and Na(+)-K(+)-ATPase activity.
  • Analysis of protein expression for vascular endothelial growth factor, fibronectin, basic fibroblast growth factor, matrix metalloproteinase (MMP)-2, MMP-9, nuclear factor kappa (NF-κ)B (p50, p65), p-p38, p-JNK, and p-focal adhesion kinase (FAK).
  • Measurement of interleukin (IL)-6 and IL-8 release.

Main Results:

  • PCA demonstrated dose-dependent inhibition of NSCLC cell proliferation and induced apoptosis.
  • PCA treatment led to mitochondrial membrane destabilization and altered apoptotic protein expression.
  • PCA suppressed the expression of pro-angiogenic and pro-metastatic factors, including vascular endothelial growth factor, fibronectin, MMP-2, and MMP-9.
  • PCA downregulated the activation of key signaling pathways such as NF-κB, MAPK (p38, JNK), and FAK, consequently reducing cytokine and growth factor production.

Conclusions:

  • Protocatechuic acid (PCA) exhibits significant anticancer properties against nonsmall cell lung cancer (NSCLC) cells.
  • PCA exerts its effects by inducing apoptosis, destabilizing mitochondrial membranes, and inhibiting critical signaling pathways involved in proliferation, angiogenesis, and metastasis.
  • These findings suggest that PCA holds promise as a potential therapeutic agent for NSCLC treatment.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

9.7K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K